Table 6.
Variable | 6-mo GBS persistent at 1 y, N = 17 (30.9%) | 6-mo GBS resolved by 1 y, N = 38 (69.1%) | p Value |
---|---|---|---|
GERD-HRQL at 6 mo | |||
Total score, median (IQR) | 29 (14–31) | 11 (8–21) | 0.033 |
Heartburn item, median (IQR) | 0 (1–2) | 0 (0–2) | 0.653 |
Regurgitation item, median (IQR) | 2 (0–3) | 0 (0–2) | 0.226 |
Dysphagia item, median (IQR) | 3 (2–5) | 2 (0–3) | 0.008 |
Gas-bloat item, median (IQR) | 5 (4–5) | 4 (4–5) | 0.211 |
Freedom from proton pump inhibitor use, % | 80 | 91.7 | 0.343 |
Patient satisfaction, % | 53.3 | 84.2 | 0.032 |
GERD-HRQL at 1 y | |||
Total score, median (IQR) | 26 (15–36) | 7 (4–17) | 0.0007 |
Heartburn item, median (IQR) | 1 (0–2) | 0 (0–2) | 0.168 |
Regurgitation item, median (IQR) | 2 (0–4) | 0 (0–1) | 0.026 |
Dysphagia item, median (IQR) | 3 (2–4) | 1 (0–2) | 0.002 |
Gas-bloat item, median (IQR) | 4 (4–5) | 2 (1–3) | <0.0001 |
Freedom from PPI use, % | 69.2 | 96.9 | 0.020 |
Patient satisfaction, % | 56.3 | 80 | 0.047 |
Simethicone use, % | 52.9 | 39.5 | 0.367 |
pH normalization, % | 75 | 80 | 0.681 |
GBS, gas-bloat syndrome; GERD-HRQL, GERD health-related quality of life; IQR, interquartile range.